DOI: 10.1002/ccr3.73659 ISSN: 2050-0904
Medication‐Related Osteonecrosis of the Jaw After Dental Extractions During High‐Dose Denosumab Therapy in a Patient With Paget's Disease: A Case Report
Toktam Zamani, Pegah Mosannen Mozaffari, Kazem Anvari, Najmeh Anbiaee, Khashayar Famili, Ali Mirzaei, Fatemeh Fallah Toosi, Abolfazl ShafieeABSTRACT
Patients with Paget's disease who receive high‐dose denosumab may develop medication‐related osteonecrosis of the jaw, particularly after dental extractions. Pre‐treatment dental assessment, careful risk communication, accurate staging, and coordinated conservative and surgical management are essential. Platelet‐rich fibrin may be used only as an adjunct, not as an established standard treatment.